herenciageneticayenfermedad: Breast Cancer

miércoles, 20 de diciembre de 2017

Breast Cancer - Dec 19, 2017 Edition

	December 19, 2017
	Breast Cancer
	The latest breast cancer news from News Medical

	Bi-annual MRI beats mammograms in detecting breast cancer among women with genetic risk Intensive surveillance including a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) exam every six months was far more effective in detecting breast cancer in younger women with a high-risk genetic profile than an annual mammogram, according to a research team based at the University of Chicago Medicine and the University of Washington, Seattle.

	Mutational patterns could identify breast cancer patients most likely to respond to platinum-based chemotherapy The presence in advanced breast cancer of mutational signatures characteristic of homologous recombination deficiency (HRD) was associated with improved clinical outcomes to treatment with platinum-based chemotherapy.

			Study suggests new treatment option for most lethal form of breast cancer The most lethal form of breast cancer could have a new treatment option, according to new research out of the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine.

			PARP inhibitor can be new treatment option for patients with metastatic breast cancer, BRCA mutations In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.

			Soy foods, cruciferous vegetables may reduce breast cancer treatment’s side effects Consuming soy foods (such as soy milk, tofu and edamame) and cruciferous vegetables (such as cabbages, kale, collard greens, bok choy, Brussels sprouts, and broccoli) may be associated with a reduction in common side effects of breast cancer treatment in breast cancer survivors, say a team of scientists led by Georgetown Lombardi Comprehensive Cancer Center.

	Myriad Genetics announces new data on EndoPredict test at 2017 San Antonio Breast Cancer Symposium Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced new results from two studies with EndoPredict are being featured at the 2017 San Antonio Breast Cancer Symposium in San Antonio, Texas.

	Guidelines for MRI breast cancer screening not followed in community settings Guidelines are not being followed to ensure that breast cancer screening of high risk women, such as those with a strong family history of breast cancer, includes an additional MRI (magnetic resonance imaging) scan.

	3D mammography may help rein in cancer screening costs Although digital breast tomosynthesis, or 3-D mammography, costs more than a digital mammography screening, it actually may help rein in cancer screening costs, according to preliminary findings presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the 2017 San Antonio Breast Cancer Symposium.

	Simple blood test shows promise to predict risk of breast cancer relapse A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to predict high or low risk of a breast cancer relapse.

	Many breast cancer patients do not feel fully informed about their treatment options, say researchers A research team in the U.S. has found that most women who undergo breast cancer operations do not feel fully informed about their treatment options when they decide on which procedure to undergo.

	Study indicates decline in use of chemotherapy for early stage breast cancer patients A study of nearly 3,000 women with early stage breast cancer indicates a recent, significant decline in the use of chemotherapy despite the lack of any change in national treatment recommendations or guidelines, according to researchers at the Stanford University School of Medicine and the University of Michigan.

	Inherited gene variation may be to blame for poor survival of patients with early-onset breast cancer A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

	Researchers generate 3D cell cultures to investigate mechanisms of drug resistance in breast cancer An international research team headed by the University of Bern and the Netherlands Cancer Institute has developed 3D cell cultures in which genes can be specifically modified. They allow the study of genes that may cause therapy resistance in breast cancer.

	Cancer risk with birth control pills emerges again in latest study A large published study that was reported in the journal New England Journal of Medicine, showed that there is a small but significant risk of breast cancer associated with regular use of hormonal birth control pills.

	Extramammary Paget’s Disease Classification and Diagnosis As Extramammary Paget’s Disease (EMPD) includes a range of locations, the diagnosis should be made using additional measures such as colonoscopy, mammography, cervical cytology, papanicolau staining, and colposcopy. In addition to biopsies that are performed to find the extent of the disease, some physicians also use noninvasive imaging procedures such as in vivo reflectance confocal microscopy.

	Relieving Symptoms of Cystic Fibrosis with Exercise We know that exercise is beneficial in helping someone to maintain their lung function, stay strong and active and maintain a good quality of life. We also know that exercise can complement ‘airway clearance techniques’ – breathing exercises prescribed by physiotherapists to help clear the lungs of mucus.

	Tgen And Baylor secure federal grant to develop early detection system for pancreatic cancer A group of the nation's premier cancer researchers led by the Baylor Scott & White Research Institute and the Translational Genomics Research Institute -- has secured a $5.13 million federal grant to develop an early detection system for pancreatic cancer, the nation's third-leading cause of cancer-related death.